| (AUD) | Jun 2024 | Y/Y change |
|---|---|---|
| Revenue | 3.57M | 7.38% |
| Operating expense | — | — |
| Net income | -6.48M | 3.97% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PIQ.AX returned -46.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -74.8% |
| 1 year | -46.8% |
| 5 years | -85.0% |
| 10 years | -31.2% |
| All-time high | $1.34 (Jan 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PIQ.AX would be worth today ›No. Proteomics International Laboratories Ltd has not paid a dividend in the past 12 months.
Proteomics International Laboratories Ltd is part of the Healthcare sector.
Proteomics International Laboratories Ltd has a market cap of 27.29M AUD, based on the latest quote.
